Veterinary Medicines

Addimag 240 mg/ml + 126 mg/ml solution for infusion for cattle

Authorised
  • Magnesium chloride hexahydrate
  • Calcium gluconate monohydrate
Download as PDF

Product identification

Medicine name:
Addimag 240 mg/ml + 126 mg/ml Solution pour perfusion
Addimag 240 mg/ml + 126 mg/ml Oplossing voor infusie
Addimag 240 mg/ml + 126 mg/ml Infusionslösung
Addimag 240 mg/ml + 126 mg/ml solution for infusion for cattle
Active substance:
  • Magnesium chloride hexahydrate
  • Calcium gluconate monohydrate
Target species:
  • Cattle
Route of administration:
  • Solution for infusion

Product details

Active substance and strength:
  • Magnesium chloride hexahydrate
    126.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate monohydrate
    240.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for solution for infusion
Withdrawal period by route of administration:
  • Solution for infusion
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • 750 ml square shaped clear polypropylene (PP) bottle with a bromobutyl rubber stopper and an aluminium screw cap.
  • 500 ml square shaped clear polypropylene (PP) bottle with a bromobutyl rubber stopper and an aluminium screw cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V660952
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0352/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/04/2024
Download
French (PDF)
Published on: 24/04/2024
Download
German (PDF)
Published on: 24/04/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/04/2024
Download
French (PDF)
Published on: 24/04/2024
Download
German (PDF)
Published on: 24/04/2024
Download

Combined File of all Documents

English (PDF)
Published on: 25/04/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/04/2024
Download
French (PDF)
Published on: 24/04/2024
Download
German (PDF)
Published on: 24/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."